Biomerica Inc (BMRA) – Strategy, SWOT and Corporate Finance Report

Biomerica Inc (BMRA) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Biomerica Inc (Biomerica) develops, manufactures, and markets medical diagnostic products used for the early detection and monitoring of chronic diseases and medical conditions. The company’s diagnostic test kits are used to analyze blood, urine and fecal specimens of the patient to diagnose various diseases and medical complications. It focuses on the development of products for diabetes, gastrointestinal, food intolerances and esoteric tests by utilizing enzyme immunoassay technology. Biomerica’s diagnostic tests are used by hospitals, clinical laboratories, physician’s offices and consumers around the world. The company distributes products in Americas, Europe, Asia, and the Middle East. Biomerica is headquartered in Irvin, California, the US.

Scope

• Detailed information on Biomerica Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Biomerica Inc in the form of a SWOT analysis

• An in-depth view of the business model of Biomerica Inc including a breakdown and examination of key business segments

• News about Biomerica Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Biomerica Inc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Biomerica Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Biomerica Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

DiscoveRx Corp

Alfa Scientific Designs Inc

Calbiotech Inc

ALPCO Diagnostics

BG Medicine Inc

Aalto Scientific Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Biomerica Inc - Key Facts

Biomerica Inc - Key Employees

Biomerica Inc - Key Employee Biographies

Biomerica Inc - Major Products and Services

Biomerica Inc - History

Biomerica Inc - Company Statement

Biomerica Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Biomerica Inc - Business Description

Geographical Segment: Asia

Performance

Geographical Segment: Europe

Performance

Geographical Segment: Middle East

Performance

Geographical Segment: North America

Performance

Geographical Segment: South America

Performance

R&D Overview

Biomerica Inc - SWOT Analysis

SWOT Analysis - Overview

Biomerica Inc - Strengths

Biomerica Inc - Weaknesses

Biomerica Inc - Opportunities

Biomerica Inc - Threats

Biomerica Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Biomerica Inc, Medical Equipment, Deals By Year, 2017 to YTD 2023

Biomerica Inc, Medical Equipment, Deals By Type, 2017 to YTD 2023

Biomerica Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

Aug 28, 2023: Diagnostics Industry Leader Jack Kenny Joins Biomerica’s Board of Directors

Jun 21, 2023: Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients

Apr 14, 2023: Biomerica Reports Q3 Fiscal 2023 Results

Jan 13, 2023: Biomerica Reports Financial Results for Fiscal 2023 Second Quarter Ended November 30, 2022

Jan 10, 2023: Biomerica Appoints Mayo Clinic Gastroenterologist, Dr. Brian E. Lacy, to the Company’s Scientific Advisory Board

Nov 02, 2022: Biomerica InFoods IBS data presented at the 2022 American College of Gastroenterology (ACG) Annual Scientific Meeting

Oct 13, 2022: Biomerica Reports 30% Increase in Revenues for Fiscal Q1 2023 vs. Fiscal Q1 2022

Aug 30, 2022: Biomerica Plans Launch of InFoods IBS Test; Names Robert Carlson as Chief Commercial Officer

Aug 29, 2022: Biomerica Reports Fiscal 2022 Year End Results

Jun 23, 2022: Biomerica to Participate at BTIG Biotech Conference

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Biomerica Inc, Key Facts

Biomerica Inc, Key Employees

Biomerica Inc, Key Employee Biographies

Biomerica Inc, Major Products and Services

Biomerica Inc, History

Biomerica Inc, Subsidiaries

Biomerica Inc, Key Competitors

Biomerica Inc, Annual Ratios

Biomerica Inc, Annual Ratios (Cont…1)

Biomerica Inc, Interim Ratios

Biomerica Inc, Medical Equipment, Deals By Year, 2017 to YTD 2023

Biomerica Inc, Medical Equipment, Deals By Type, 2017 to YTD 2023

Biomerica Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Biomerica Inc, Performance Chart (2019 – 2023)

Biomerica Inc, Ratio Charts

Biomerica Inc, Medical Equipment, Deals By Year, 2017 to YTD 2023

Biomerica Inc, Medical Equipment, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports